Tyra Biosciences, Inc.
TYRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $795,327 | $591,450 | $318,318 | $583,077 |
| - Cash | $91,966 | $58,006 | $251,213 | $302,182 |
| + Debt | $6,222 | $6,496 | $2,622 | $1,183 |
| Enterprise Value | $709,583 | $539,940 | $69,727 | $282,078 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$103,658 | -$79,588 | -$58,631 | -$26,148 |
| % Margin | – | – | – | – |
| Net Income | -$86,481 | -$69,134 | -$55,325 | -$26,294 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.51 | -1.62 | -1.23 | -0.63 |
| % Growth | 6.8% | -31.7% | -95.2% | – |
| Operating Cash Flow | -$69,774 | -$50,139 | -$50,285 | -$23,745 |
| Capital Expenditures | -$664 | -$770 | -$559 | -$661 |
| Free Cash Flow | -$70,438 | -$50,909 | -$50,844 | -$24,406 |